Clinical trial NCT04977986
Status: Completed, results awaitedPhase 3Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome
- Record number
- NCT04977986
- Status
- Completed, results awaited
- Type and phase
- Clinical trial, phase 3
- Participants
- 257 (actual)
- Condition (as registered)
- Fragile X Syndrome, Fragile X Syndrome (FXS)
- Countries
- Australia, Ireland, New Zealand, United Kingdom, United States
- Topic in the guide
- Outside the topics in the guide
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: September 13, 2021
- End of data collection for primary results: August 29, 2025
- Trial completion: August 29, 2025
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Completed, results awaited.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Thinking of taking part? Which specialist to see